Real-time characterisation of microbe-induced inflammation using a novel zebrafish larval corneal injury and

Kelvin K W Cheng1, Carl S Tucker2, Justyna Cholewa-Waclaw3

  • 1Centre for Inflammation Research, Institute for Regeneration and Repair, University of Edinburgh, Edinburgh, UK. kcheng@ed.ac.uk.

Communications Biology
|April 14, 2026
PubMed

Insights

A new zebrafish model allows real-time observation of immune cell dynamics in microbial keratitis (MK). This powerful tool aids in discovering new immunomodulators to combat this leading cause of blindness.

Area of Science:

  • Ophthalmology
  • Immunology
  • Developmental Biology

Background:

  • Microbial keratitis (MK) is a significant global cause of blindness.
  • Current treatments for MK rely heavily on antimicrobials, with limited immunomodulatory options.
  • Dysregulated immune responses play a critical role in MK pathogenesis, highlighting an unmet clinical need.

Purpose of the Study:

  • To develop a novel zebrafish larvae model for studying microbial keratitis (MK).
  • To enable real-time, high-resolution analysis of immune cell dynamics in vivo.
  • To provide a platform for discovering and screening new immunomodulators for MK treatment.

Main Methods:

  • Utilized transgenic zebrafish lines with fluorescently labeled neutrophils, macrophages, and basal epithelial cells.
  • Induced corneal injury and infection with live bacteria in zebrafish larvae.
  • Analyzed immune cell recruitment, speed, and migratory distance in response to injury and inflammatory mediators.

Main Results:

  • Corneal injury rapidly triggered immune cell recruitment, amplified by pro-inflammatory mediators (fMLF, LTB4).
  • Bacterial infection induced robust and sustained neutrophil and macrophage recruitment.
  • Observed increased neutrophil speed and migratory distance during infection.

Conclusions:

  • The developed zebrafish larvae MK model allows dynamic in vivo visualization of immune cell dynamics.
  • This model offers a powerful and scalable platform for accelerating the discovery of novel immunomodulators for microbial keratitis.
  • The study addresses a critical unmet need in MK treatment by providing advanced research capabilities.

Related Concept Videos